Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells

By Fedejko-Kap Barbara   Niemira Magdalena   Radominska-Pandya Anna   Mazerska Zofia  

Xenobiotica, Vol. 41, Iss. 12, 2011-12 ,pp. : 1044-1055

Informa Healthcare

Access to resources Recommend Favorite

Liposomes targeting tumour stromal cells

By Kuijpers Sylvia A.   Coimbra Maria J.   Storm Gert   Schiffelers Raymond M.  

Molecular Membrane Biology, Vol. 27, Iss. 7, 2010-10 ,pp. : 328-340

Informa Healthcare

Access to resources Recommend Favorite

Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure

By Chang Jeff   Leong Rupert WL  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 27-36

Informa Healthcare

Access to resources Recommend Favorite

In vivo study on the effects of curcumin on the expression profiles of anti-tumour genes (VEGF, CyclinD1 and CDK4) in liver of rats injected with DEN

By Huang Chu   Huang Wei   Zhang Ge   Tang Dan  

Molecular Biology Reports, Vol. 40, Iss. 10, 2013-10 ,pp. : 5825-5831

Springer Publishing Company

Access to resources Recommend Favorite

Identification and reactivity of the major metabolite (β-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans

By Zhou S. F.   Paxton J. W.   Tingle M. D.   Kestell P.   Jameson M. B.   Thompson P. I.   Baguley B. C.  

Xenobiotica, Vol. 31, Iss. 5, 2001-05 ,pp. : 277-293

Informa Healthcare

Access to resources Recommend Favorite